Date and time: Tue 06-Nov-2018, 12:40 pm-1:55 pm

Room: Silent theatre 1 - Hall 4

These theatres provide an area for accepted abstract submitters to present their research in 5 minute presentations.

The abstract presentations in this session are:

12.40 – Gianina-Ioana Postavaru, Living with and beyond cancer: Self-managing chemotherapy side-effects and eating behaviours

12.46 – Aisha Farooq, A retrospective audit to evaluate the impact on overall survival in melanoma patients treated with pembrolizumab [Keytruda], who have received a dose banded dose versus patient specific dose.

12.52 – Rebecca Fish, A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): A patient and health care professional consensus

12.58 – Erin A Marshall, XIST and miRNA sequestration: Insights into lncRNA-mediated gene regulation

13.04 – Grace Tan, Antibiotic use and efficacy of small molecule inhibitors in patients with advanced cancer

13.10 – Hafsa Abbas, Glyoxalase 1 overexpression associated multidrug resistance in cancer chemotherapy

13.16 – Amanda Swan, Vertebral fractures in patients treated with FOLFIRI-Cetuximab at the Edinburgh Cancer Centre

13.22 – Somnath Mukherjee, SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component

13.28 – Rhian Gabe, The Yorkshire Lung Screening Trial

13.34 – Chiara Asselborn, Selective vulnerability of colorectal cancer (CRC) organoids to hypoxia-mimetic drug

13.40 – Debbie Cavers, Living with and beyond cancer with comorbid illness: a qualitative systematic review

13.46 – Michelle McCully, What is fuelling overweight and obesity and which policy actions are needed? WCRF/ AICR Third Expert Report